Signaling chromatin to make muscle

Current Opinion in Cell Biology

Volumn 14, Issue 6, 2002, Pages 763-772

  McKinsey, Timothy A ^b   Zhang, Chun Li ^a   Olson, Eric N ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Myogen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE METHYLTRANSFERASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIN DEPENDENT KINASE; HELIX LOOP HELIX PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; LYSINE METHYLTRANSFERASE; METHYLTRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MYOCYTE ENHANCER FACTOR 2; MYOD PROTEIN; OKADAIC ACID; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; PROTEIN P300; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRICHOSTATIN A; UNCLASSIFIED DRUG; ACYLTRANSFERASE; DNA BINDING PROTEIN; MYOCYTE SPECIFIC ENHANCER BINDING FACTOR 2; MYOCYTE-SPECIFIC ENHANCER-BINDING FACTOR 2; MYOGENIC FACTOR; PROTEIN ARGININE METHYLTRANSFERASE; SACCHAROMYCES CEREVISIAE PROTEIN;

CHROMATIN STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART HYPERTROPHY; MUSCLE DEVELOPMENT; MYOPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; SKELETAL MUSCLE; ANIMAL; CARDIOMEGALY; CHROMATIN; ENZYMOLOGY; GENE EXPRESSION REGULATION; HEART MUSCLE; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ACETYLTRANSFERASES; ANIMALS; CARDIOMEGALY; CHROMATIN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HUMANS; MUSCLE, SKELETAL; MYOCARDIUM; MYOD PROTEIN; MYOGENIC REGULATORY FACTORS; PROTEIN-ARGININE N-METHYLTRANSFERASE; SACCHAROMYCES CEREVISIAE PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 1842843176     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(02)00389-7     Document Type: Review

References (49)

1. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature. 403:2000;41-45.
2. McKinsey T.A., Zhang C.L., Olson E.N. Control of muscle development by dueling HATs and HDACs. Curr Opin Genet Dev. 11:2001;497-504.
3. Arnold H.H., Winter B. Muscle differentiation: more complexity to the network of myogenic regulators. Curr Opin Genet Dev. 8:1998;539-544.
4. Black B.L., Olson E.N. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol. 14:1998;167-196.
5. Puri P.L., Sartorelli V., Yang X.J., Hamamori Y., Ogryzko V.V., Howard B.H., Kedes L., Wang J.Y., Graessmann A., Nakatani Y., Levrero M. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell. 1:1997;35-45.
6. Polesskaya A., Naguibneva I., Fritsch L., Duquet A., Ait-Si-Ali S., Robin P., Vervisch A., Pritchard L.L., Cole P., Harel-Bellan A. CBP/p300 and muscle differentiation: no HAT, no muscle. EMBO J. 20:2001;6816-6825. This paper is the first to demonstrate that the histone acetyltransferase activity of p300/CBP is required for skeletal myogenesis. The authors employ a novel p300/CBP-specific inhibitor first described by Lau et al. (2000) [7••] (see below).
7. Lau O.D., Kundu T.K., Soccio R.E., Ait-Si-Ali S., Khalil E.M., Vassilev A., Wolffe A.P., Nakatani Y., Roeder R.G., Cole P.A. HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol Cell. 5:2000;589-595. This paper describes novel peptide CoA conjugates that act as specific inhibitors of histone acetyltransferases. These inhibitors will provide valuable tools to address the role of histone acetyltransferases in the control of different biological processes.
8. Eckner R., Yao T.P., Oldread E., Livingston D.M. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 10:1996;2478-2490.
9. Sartorelli V., Huang J., Hamamori Y., Kedes L. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol. 17:1997;1010-1026.
10. Chen S.L., Dowhan D.H., Hosking B.M., Muscat G.E. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. Genes Dev. 14:2000;1209-1228.
11. Chen S.L., Loffler K.A., Chen D., Stallcup M.R., Muscat G.E. The coactivator-associated arginine methyltransferase is necessary for muscle differentiation: CARM1 coactivates myocyte enhancer factor-2. J Biol Chem. 277:2002;4324-4333. This paper describes a role for the CARM1 arginine methyltransferase as a positive regulator of MEF2-dependent transcription and muscle differentiation.
12. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., Aswad D.W., Stallcup M.R. Regulation of transcription by a protein methyltransferase. Science. 284:1999;2174-2177.
13. Chen D., Huang S.M., Stallcup M.R. Synergistic, p160 coactivator-dependent enhancement of estrogen receptor function by CARM1 and p300. J Biol Chem. 275:2000;40810-40816.
14. Goodman R.H., Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14:2000;1553-1577. This is a comprehensive review of p300/CBP function and regulation.
15. Xu W., Chen H., Du K., Asahara H., Tini M., Emerson B.M., Montminy M., Evans R.M. A transcriptional switch mediated by cofactor methylation. Science. 294:2001;2507-2511.
16. McKinsey T.A., Zhang C.L., Olson E.N. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci. 27:2002;40-47.
17. Mal A., Sturniolo M., Schiltz R.L., Ghosh M.K., Harter M.L. A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program. EMBO J. 20:2001;1739-1753.
18. Puri P.L., Iezzi S., Stiegler P., Chen T.T., Schiltz R.L., Muscat G.E., Giordano A., Kedes L., Wang J.Y., Sartorelli V. Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol Cell. 8:2001;885-897. This paper describes the functional and physical interplay between HDAC1, the retinoblastoma tumour suppressor, and MyoD. HDAC1 negatively and positively regulates muscle differentiation through its association with MyoD and retinoblastoma, respectively.
19. Harbour J.W., Dean D.C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14:2000;2393-2409.
20. Bergstrom D.A., Penn B.H., Strand A., Perry R.L., Rudnicki M.A., Tapscott S.J. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol Cell. 9:2002;587-600. This paper defines the genes that are regulated by MyoD during skeletal muscle differentiation. The paper reveals that temporally restricted, promoter-specific binding of MyoD is a key mechanism for the regulation of MyoD target gene expression.
21. Lagger G., O'Carroll D., Rembold M., Khier H., Tischler J., Weitzer G., Schuettengruber B., Hauser C., Brunmeir R., Jenuwein T., Seiser C. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 21:2002;2672-2681.
22. Pflum M.K., Tong J.K., Lane W.S., Schreiber S.L. Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation. J Biol Chem. 276:2001;47733-47741.
23. Cai R., Kwon P., Yan-Neale Y., Sambuccetti L., Fischer D., Cohen D. Mammalian histone deacetylase 1 protein is posttranslationally modified by phosphorylation. Biochem Biophys Res Commun. 283:2001;445-453.
24. Galasinski S.C., Resing K.A., Goodrich J.A., Ahn N.G. Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions. J Biol Chem. 277:2002;19618-19626.
25. David G., Neptune M.A., DePinho R.A. SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J Biol Chem. 277:2002;23658-23663.
26. Jackson P.K. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev. 15:2001;3053-3058.
27. Blau H.M., Epstein C.J. Manipulation of myogenesis in vitro: reversible inhibition by DMSO. Cell. 17:1979;95-108.
28. Fiszman M.Y., Montarras D., Wright W., Gros F. Expression of myogenic differentiation and myotube formation by chick embryo myoblasts in the presence of sodium butyrate. Exp Cell Res. 126:1980;31-37.
29. Johnston L.A., Tapscott S.J., Eisen H. Sodium butyrate inhibits myogenesis by interfering with the transcriptional activation function of MyoD and myogenin. Mol Cell Biol. 12:1992;5123-5130.
30. Steinbac O.C., Wolffe A.P., Rupp R.A. Histone deacetylase activity is required for the induction of the MyoD muscle cell lineage in Xenopus. Biol Chem. 381:2000;1013-1016.
31. Iezzi S., Cossu G., Nervi C., Sartorelli V., Puri P.L. Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases. Proc Natl Acad Sci USA. 99:2002;7757-7762. This paper demonstrates that three distinct histone deacetylase inhibitors, trichostatin A, butyrate and valproic acid, can either stimulate or inhibit muscle differentiation, depending on when and for how long they are added to cultured myoblasts.
32. Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A., Olson E.N. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell. 110:2002;479-488. This paper demonstrates that class II histone deacetylases (HDACs) are potent repressors of cardiac hypertrophy. Signals that promote hypertrophic growth stimulate a HDAC kinase that phosphorylates and inactivates HDAC4, -5, -7 and -9. A HDAC9 knockout mouse spontaneously develops cardiac hypertrophy over time and is hypersensitive to hypertrophic cues at earlier timepoints.
33. Zhang C.L., McKinsey T.A., Olson E.N. Association of class II histone deacetylases with heterochromatin protein 1: a potential role for histone methylation in the control of muscle differentiation. Mol Cell Biol. 22:2002;7302-7312.
34. Kirsh O., Seeler J.S., Pichler A., Gast A., Muller S., Miska E., Mathieu M., Harel-Bellan A., Kouzarides T., Melchior F., Dejean A. The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J. 21:2002;2682-2691.
35. Wu H., Naya F.J., McKinsey T.A., Mercer B., Shelton J.M., Chin E.R., Simard A.R., Michel R.N., Bassel-Duby R., Olson E.N., Williams R.S. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J. 19:2000;1963-1973.
36. Wu H., Rothermel B., Kanatous S., Rosenberg P., Naya F.J., Shelton J.M., Hutcheson K.A., DiMaio J.M., Olson E.N., Bassel-Duby R., Williams R.S. Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J. 20:2001;6414-6423.
37. Wu H., Olson E.N. Activation of the MEF2 transcription factor in skeletal muscles from myotonic mice. J Clin Invest. 109:2002;1327-1333. This paper demonstrates that MEF2 transcriptional activity is highly elevated in the muscles of arrested development of righting response (ADR) mouse. This mouse contains a mutation in the chloride channel 1 (CLCN1) gene that leads to the development of non-dystrophic myotonia characterized by increased numbers of slow/oxidative skeletal muscle fibres. Class II histone deacetylase protein levels are severely reduced in these muscles, suggesting that the MEF2 activation observed in these mice may be coupled to histone deacetylase degradation.
38. Frey N., McKinsey T.A., Olson E.N. Decoding calcium signals involved in cardiac growth and function. Nat Med. 6:2000;1221-1227.
39. Boyes J., Byfield P., Nakatani Y., Ogryzko V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature. 396:1998;594-598.
40. Blobel G.A., Nakajima T., Eckner R., Montminy M., Orkin S.H. CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. Proc Natl Acad Sci USA. 95:1998;2061-2066.
41. Garcia-Rodriguez C., Rao A. Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP). J Exp Med. 187:1998;2031-2036.
42. Gusterson R., Brar B., Faulkes D., Giordano A., Chrivia J., Latchman D. The transcriptional co-activators CBP and p300 are activated via phenylephrine through the p42/p44 MAPK cascade. J Biol Chem. 277:2002;2517-2524.
43. Blaeser F., Ho N., Prywes R., Chatila T.A. Ca(2+)-dependent gene expression mediated by MEF2 transcription factors. J Biol Chem. 275:2000;197-209.
44. Morin S., Charron F., Robitaille L., Nemer M. GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J. 19:2000;2046-2055.
45. Lu J., McKinsey T.A., Zhang C.L., Olson E.N. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell. 6:2000;233-244.
46. de la Serna I.L., Roy K., Carlson K.A., Imbalzano A.N. MyoD can induce cell cycle arrest but not muscle differentiation in the presence of dominant negative SWI/SNF chromatin remodeling enzymes. J Biol Chem. 276:2001;41486-41491.
47. de la Serna I.L., Carlson K.A., Imbalzano A.N. Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. Nat Genet. 27:2001;187-190.
48. Fischle W., Dequiedt F., Hendzel M.J., Guenther M.G., Lazar M.A., Voelter W., Verdin E. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell. 9:2002;45-57. This paper demonstrates that the class I histone deacetylase, HDAC3, acts in trans to stimulate class II HDAC activity. HDAC3 is recruited to class II HDAC complexes via the SMRT and N-CoR co-repressors.
49. Kao H.Y., Downes M., Ordentlich P., Evans R.M. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev. 14:2000;55-66.